Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works citing this work

2 works

Work: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants

  1. COVID-19 Vaccines - Current State and Perspectives

    Ibrokhim Y. Abdurakhmonov

    BookSARS-CoV-2 and COVID-19 ResearchIntechOpen eBooks20221 citations
    ABI

  2. Coronavirus spike protein-based vaccines. Vaccine delivery systems

    Akmal M. Asrorov, Mirzakamol S. Ayubov, Bin Tu +6

    ArticleSARS-CoV-2 and COVID-19 ResearchMedicine in Drug Discovery20240 citations
    ABI